Alexion Pharma (ALXN) Updates on Commissioning of Rhode Island Facility as Second Supply Source for Soliris
Tweet Send to a Friend
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today provided updates on the regulatory review and approval, or commissioning, of Alexion's Rhode Island ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
